Amundi Raises Stock Position in HCA Healthcare, Inc. $HCA

Amundi grew its holdings in shares of HCA Healthcare, Inc. (NYSE:HCA) by 36.2% during the 2nd quarter, according to its most recent filing with the Securities and Exchange Commission. The institutional investor owned 394,665 shares of the company’s stock after buying an additional 104,817 shares during the quarter. Amundi’s holdings in HCA Healthcare were worth $149,199,000 at the end of the most recent reporting period.

Several other institutional investors have also modified their holdings of the stock. Brighton Jones LLC purchased a new stake in HCA Healthcare during the 4th quarter valued at $1,021,000. Chicago Partners Investment Group LLC purchased a new stake in shares of HCA Healthcare in the first quarter valued at $340,000. Zions Bancorporation National Association UT purchased a new position in shares of HCA Healthcare during the 1st quarter worth about $98,000. Townsquare Capital LLC lifted its stake in HCA Healthcare by 24.2% in the first quarter. Townsquare Capital LLC now owns 3,117 shares of the company’s stock worth $1,077,000 after purchasing an additional 607 shares during the last quarter. Finally, Koss Olinger Consulting LLC bought a new position in shares of HCA Healthcare during the first quarter valued at approximately $326,000. 62.73% of the stock is owned by institutional investors.

Insiders Place Their Bets

In related news, EVP Michael R. Mcalevey sold 3,892 shares of the business’s stock in a transaction on Wednesday, November 5th. The stock was sold at an average price of $473.79, for a total transaction of $1,843,990.68. Following the transaction, the executive vice president directly owned 3,487 shares in the company, valued at $1,652,105.73. The trade was a 52.74% decrease in their position. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. 1.30% of the stock is currently owned by company insiders.

HCA Healthcare Price Performance

Shares of NYSE HCA opened at $486.40 on Monday. The business has a fifty day moving average price of $459.97 and a 200 day moving average price of $410.43. HCA Healthcare, Inc. has a 1-year low of $289.98 and a 1-year high of $520.00. The stock has a market capitalization of $110.99 billion, a P/E ratio of 18.80, a price-to-earnings-growth ratio of 1.44 and a beta of 1.36.

HCA Healthcare (NYSE:HCA) last released its quarterly earnings results on Friday, October 24th. The company reported $6.96 EPS for the quarter, beating the consensus estimate of $5.64 by $1.32. HCA Healthcare had a net margin of 8.53% and a negative return on equity of 792.25%. The business had revenue of $19.16 billion during the quarter, compared to analyst estimates of $18.55 billion. During the same period in the prior year, the firm posted $4.90 earnings per share. The company’s quarterly revenue was up 9.6% on a year-over-year basis. HCA Healthcare has set its FY 2025 guidance at 27.000-28.000 EPS. As a group, equities research analysts anticipate that HCA Healthcare, Inc. will post 24.98 earnings per share for the current fiscal year.

HCA Healthcare Dividend Announcement

The firm also recently declared a quarterly dividend, which will be paid on Monday, December 29th. Stockholders of record on Monday, December 15th will be given a dividend of $0.72 per share. The ex-dividend date of this dividend is Monday, December 15th. This represents a $2.88 dividend on an annualized basis and a dividend yield of 0.6%. HCA Healthcare’s dividend payout ratio is presently 11.13%.

Wall Street Analysts Forecast Growth

Several equities analysts have commented on HCA shares. TD Cowen upped their price objective on HCA Healthcare from $380.00 to $490.00 and gave the company a “buy” rating in a research report on Monday, October 27th. Weiss Ratings reaffirmed a “buy (b)” rating on shares of HCA Healthcare in a research note on Monday, December 1st. UBS Group upped their target price on shares of HCA Healthcare from $495.00 to $525.00 and gave the stock a “buy” rating in a research note on Monday, October 27th. Morgan Stanley set a $425.00 price target on HCA Healthcare in a report on Monday, October 27th. Finally, Truist Financial upped their target price on HCA Healthcare from $460.00 to $495.00 and gave the stock a “buy” rating in a report on Monday, October 27th. Fourteen research analysts have rated the stock with a Buy rating and ten have given a Hold rating to the company’s stock. According to MarketBeat.com, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $474.53.

HCA Healthcare Company Profile

HCA Healthcare, Inc, through its subsidiaries, owns and operates hospitals and related healthcare entities in the United States. It operates general and acute care hospitals that offers medical and surgical services, including inpatient care, intensive care, cardiac care, diagnostic, and emergency services; and outpatient services, such as outpatient surgery, laboratory, radiology, respiratory therapy, cardiology, and physical therapy.